Updated Guidance On Expedited Review Removes 2002 MDUFMA Conditions
This article was originally published in The Gray Sheet
Executive Summary
FDA will no longer require device firms to satisfy extra conditions in order for their expedited PMA applications to fall under FDA review performance goals, according to guidance released Feb. 29